Elena Gazzano

RETRACTED: Schiavello et al. Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma. Cancers 2021, 13, 1138

Martina Schiavello, Elena Gazzano, Loredana Bergandi, Francesca Silvagno et autres

The journal retracts the article titled "Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma" [...].

it (code pays fourni par la source)

Biocatalytic conversion of the natural compound bergamottin into novel bioactive epoxy-derivatives using engineered cytochrome P450 BM3

Mariusz Brzoski, Alessandro Barge, Elena Gazzano, Danilo Correddu et autres

The bioconversion of natural products by cytochrome P450 enzymes can represent a sustainable alternative to classical chemical synthesis. In this study, we applied a colorimetric assay based on styrene oxidation, to select natural compounds as candidate substrates for cytochrome P450-mediated biocatalysis. One …

it (code pays fourni par la source)

Biocatalytic production of a monoamine oxidase B/catechol-O-methyltransferase inhibitor from piperine by engineered P450 BM3.

Mariusz Brzoski, Samuele Irudal, Elena Gazzano, Roberto Buscaino et autres

The single-step biotransformation of the natural compound piperine into a known dual inhibitor of monoamine oxidase B (MAO-B) and catechol-O-methyltransferase (COMT), was achieved by cytochrome P450 BM3 wild-type and the D251G/Q307H double mutant. This compound is used for research in neurodegenerative disorders, …

it (code pays fourni par la source)

“Nitric Oxide Donors for Biomedical Applications: A Themed Issue Dedicated to Professor Alberto Gasco”: Special Issue Editorial Overview

Federica Sodano, Elena Gazzano, Roberta Fruttero

The Guest Editors Federica Sodano, Elena Gazzano, and Roberta Fruttero are pleased to present this editorial overview of the Special Issue entitled "Nitric Oxide Donors for Biomedical Applications: A Themed Issue Dedicated to Professor Alberto Gasco" [...].

it (code pays fourni par la source)

154 Toward a General Approach to Risk Assessment of Naturally Occurring Asbestos and Asbestos-Like Minerals: the case of Fibrous Antigorite

Francesco Turci, Jasmine Rita Petriglieri, Luca Barale, Elena Gazzano et autres

Abstract The natural occurrence of asbestos and asbestos-like minerals (NOA) poses a risk to the environment and human health, notably when natural processes and anthropic activities promote fibre dispersion. Hundreds of potentially hazardous elongated mineral particles (EMPs, NIOSH 2011 definition) exist, and …

it (code pays fourni par la source)

Supplementary materials from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Legends of Supplementary Figures S1-S7; Supplementary Tables S1-S7

Supplementary Figure S2 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Expression of Pgp and MRP1 in doxorubicin-sensitive and doxorubicin-resistant osteosarcoma cells

Supplementary Figure S4 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Effects of mitochondria-targeted doxorubicin in non-transformed osteoblasts and cardiomyocytes

Supplementary Figure S3 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Effects of mitochondria-targeted doxorubicin in drug-sensitive Saos-2 cells and in their resistant variants, and in K7M2 cells

Supplementary Figure S7 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Effects of mitochondria-targeted doxorubicin on drug-sensitive osteosarcoma in vivo

Supplementary Figure S5 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Immunohistochemical analysis of drug-resistant osteosarcoma treated with mitochondria-targeted doxorubicin

Supplementary Figure S6 from Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean, Valentina Audrito et autres

Dose-response effects of mitochondria-targeted doxorubicin on drug-resistant osteosarcoma in vivo